SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Abbott India

BSE: 500488 21 Feb 2026
Healthcare
₹ 26630 ▼ -0.98%
Abbott India Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Abbott India - Share Price & Details

Market Cap
₹ 55,920.41
WAP
26,512.11
Turnover
66.54(Lakh)
TTQ
251
2 Week Avg Qty
1209
Circuit Limit
251.00/21,010.70
Stock P/E
43.5
Book Value
₹1,992
Dividend Yield
1.6
ROCE
46.2
ROE / PB
43.29 / 15.88
Face Value
10.00
PEG Ratio
2.07
EVEBITDA
₹30.4
Debt
197
CMP / FCF
63.4
Debt to equity
₹0.05
NP Ann
1,414
High price all time
37,000
Piotroski score
₹7.0
Graham Number
5,535
No. Eq. Shares
2.12
Net CF
₹269
Net profit
1,452
Price to book value
14.9
Interest Coverage
₹135.0
Low price all time
362.0
Industry PE
33.0
Reserves
₹4,212
Free Cash Flow
₹960

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
09 Nov 2025 ICICI Securities Buy ₹28,801.05 ₹34,500 16.7% moneycontrol View
17 Sep 2025 Mirae Asset Sharekhan Buy ₹30,948.25 ₹34,470 11.5% moneycontrol View
26 May 2025 ICICI Securities Buy ₹30,791.15 ₹35,750 13.7% moneycontrol View
16 May 2025 ICICI Securities Buy ₹30,560.85 ₹35,750 16% moneycontrol View
06 Feb 2025 ICICI Securities Buy ₹29,101.95 ₹32,700 10.6% moneycontrol View
08 Aug 2024 Sharekhan Buy ₹27,223 ₹32,000 13% moneycontrol View
16 May 2024 ICICI Securities Buy ₹26,545.4 ₹32,500 14.2% moneycontrol View
15 May 2024 Sharekhan Buy ₹26,434.2 ₹30,540 7.3% moneycontrol View

Price Chart

Volume Chart

Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Fabino Enterprises LtdNANANANA5.0984.8
Triochem Products Ltd2.21-1.32NA-5.380
Abbott India Limited17,938.003,759.6017,240.40176.9263,19843.5
Glenmark Pharmaceuticals Limited39450.84032.2839006.1514.285564241.8
Biocon Limited42903.0-518.041730.01.0745310125.0

Peer Comparison Chart

About Abbott India

Abbott India Ltd., with Security Code 500488, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market | FinancialContent

(27 Sep 2025)
Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector,...
Read more →

Abbott India's Goa Plant Director Munish Prashar to resign

(26 Sep 2025)
Mumbai: Abbott India has announced the resignation of Munish Prashar, Plant Director – Goa. His departure will be effective from the close...
Read more →

Some Shareholders Feeling Restless Over Abbott India Limited's (NSE:ABBOTINDIA) P/E Ratio

(26 Sep 2025)
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 28x, you may consider Abbott India Limited...
Read more →

Buy Abbott India; target of Rs 34,470: Mirae Asset Sharekhan

(18 Sep 2025)
Mirae Asset Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 34470 in its research...
Read more →

Abbott India shares gain 1.21% amid volume surge

(10 Sep 2025)
Abbott India shares experienced a notable surge, climbing 1.21% to Rs 31,000.00 in Wednesday's trading session. This increase was marked by...
Read more →

Abbott India Adjusts Evaluation Score Amid Strong ROE and Elevated Valuation Concerns

(09 Sep 2025)
Abbott India, a midcap pharmaceutical company, has recently adjusted its evaluation score, reflecting a change in technical trends.
Read more →